carmustine has been researched along with Cardiotoxicity in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| AlJohani, NI | 1 |
| Nasani, M | 1 |
| Ahmed, HE | 1 |
| Ur Rehman, J | 1 |
| Nawaz, A | 1 |
| Alzahrani, Z | 1 |
| Albeirouti, B | 1 |
| Salvi, F | 1 |
| Luminari, S | 1 |
| Tucci, A | 1 |
| Massidda, S | 1 |
| Liberati, AM | 1 |
| Stelitano, C | 1 |
| Zanni, M | 1 |
| Re, A | 1 |
| Centurioni, R | 1 |
| Freilone, R | 1 |
| Musuraca, G | 1 |
| Nassi, L | 1 |
| Patti, C | 1 |
| Arcari, A | 1 |
| Tani, M | 1 |
| Pulsoni, A | 1 |
| Pavone, V | 1 |
| Volpetti, S | 1 |
| Peli, A | 1 |
| Evangelista, A | 1 |
| Spina, M | 1 |
| Ladetto, M | 1 |
| Merli, F | 1 |
1 trial available for carmustine and Cardiotoxicity
| Article | Year |
|---|---|
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL).
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity | 2019 |
1 other study available for carmustine and Cardiotoxicity
| Article | Year |
|---|---|
Dose-adjusted bendamustine as a replacement for carmustine in autologous stem cell transplant conditioning for patients with relapsed lymphoma: A retrospective single-center study.
Topics: Bendamustine Hydrochloride; Cardiotoxicity; Carmustine; Hematopoietic Stem Cell Transplantation; Hum | 2021 |